Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Ulintz

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neuro-Oncology Advances|July 10, 2020
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1Mahmoud S Alghamri, Rohit Thalla, Ruthvik P Avvari, et al.
Breast Cancer Research and Treatment|October 28, 2019
Molecular determinants of drug response in TNBC cell linesNathan M Merrill, Eric J Lachacz, Nathalie M Vandecan, et al.
Clinical and Translational Gastroenterology|November 19, 2021
Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic PancreatitisRobert W Cowan, Erica D Pratt, Jin Muk Kang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 17, 2015
Intra-tumor genetic heterogeneity in rectal cancerKarin M Hardiman, Peter J Ulintz, Rork D Kuick, et al.
JCI Insight|April 3, 2025
Germline mutations in PPP2R1B in patients with a personal and family history of cancerSahar Mazhar, Caitlin M O'Connor, Alexis Harold, et al.
Advanced Nanobiomed Research|May 26, 2023
Blood-brain barrier remodeling in an organ-on-a-chip device shows Dkk1 to be a regulator of early metastasisTrisha M Westerhof, Benjamin A Yang, Nathan M Merill, et al.
Elife|July 29, 2021
Murine muscle stem cell response to perturbations of the neuromuscular junction are attenuated with agingJacqueline A Larouche, Mahir Mohiuddin, Jeongmoon J Choi, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Breast Cancer Research and Treatment|February 12, 2021
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestryEvelyn M Jiagge, Peter J Ulintz, Shukmei Wong, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neuro-Oncology Advances|July 10, 2020
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1Mahmoud S Alghamri, Rohit Thalla, Ruthvik P Avvari, et al.
Breast Cancer Research and Treatment|October 28, 2019
Molecular determinants of drug response in TNBC cell linesNathan M Merrill, Eric J Lachacz, Nathalie M Vandecan, et al.
Clinical and Translational Gastroenterology|November 19, 2021
Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic PancreatitisRobert W Cowan, Erica D Pratt, Jin Muk Kang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 17, 2015
Intra-tumor genetic heterogeneity in rectal cancerKarin M Hardiman, Peter J Ulintz, Rork D Kuick, et al.
JCI Insight|April 3, 2025
Germline mutations in PPP2R1B in patients with a personal and family history of cancerSahar Mazhar, Caitlin M O'Connor, Alexis Harold, et al.
Advanced Nanobiomed Research|May 26, 2023
Blood-brain barrier remodeling in an organ-on-a-chip device shows Dkk1 to be a regulator of early metastasisTrisha M Westerhof, Benjamin A Yang, Nathan M Merill, et al.
Elife|July 29, 2021
Murine muscle stem cell response to perturbations of the neuromuscular junction are attenuated with agingJacqueline A Larouche, Mahir Mohiuddin, Jeongmoon J Choi, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Breast Cancer Research and Treatment|February 12, 2021
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestryEvelyn M Jiagge, Peter J Ulintz, Shukmei Wong, et al.
Science Advances|September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapyMahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
Pageof 3